Browsing 1 studies for William Rieter
A Multicenter, Randomized, Controlled Phase 2 study: Efficacy And Safety Of I-131-1095 Radiotherapy In Combination With Enzalutamide In Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Who Are 18F-DCFPyL Prostate-Specific Membrane Antigen (PSMA)-Avid, Chemotherapy-naïve, And Progressed On Abiraterone (ARROW)
- Date Added
- January 14th, 2020
- PRO Number
- Pro00094109
- Researcher
-
William Rieter
List of Studies